ANALYSIS OF ANTIBIOTIC USAGE IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS AT THE HAI QUAN NAVAL MEDICAL INSTITUTE IN 2024
Main Article Content
Abstract
Objective: To describe the current status of antibiotic use and to analyze the appropriateness of antibiotic therapy in the treatment of community-acquired pneumonia (CAP) in adults at the Naval Medical Institute in 2024. Methods: A retrospective cross-sectional study was conducted by reviewing 101 medical records of patients diagnosed with pneumonia from January 1, 2024, to December 31, 2024. Eligible patients were aged ≥18 years, hospitalized for at least 2 days, and received antibiotic treatment during their stay at the Naval Medical Institute. Results: The majority of patients were over 65 years old (64,36%). Most patients were discharged in improved or stable condition (97,03%). Comorbidities were present in 94,05% of cases, with most having two or more coexisting diseases. Based on the CURB-65 score, most patients had mild pneumonia (73,27%). Among the 101 empirical initial antibiotic regimens used, 78 were monotherapy (77,23%). No patients underwent antimicrobial susceptibility testing (0%). The proportion of empirical antibiotic regimens that did not align with the Ministry of Health's treatment guidelines was 67,56% for mild, 31,81% for moderate, and 40% for severe pneumonia. Inappropriate total dosing was observed in 50,67% of regimens. Incorrect single-dose administration occurred in 16% of cases, and the frequency of administration was deemed inappropriate in 65,34%. Conclusion: The most commonly used monotherapy antibiotic was Cefoperazone. The most frequent combination regimen involved Penicillin and beta-lactamase inhibitors. The proportion of empirically selected regimens and dosages that did not comply with the Ministry of Health's treatment guidelines remains considerably high.
Article Details
Keywords
Antibiotics, Community-acquired pneumonia
References
2. Bộ Y tế (2015). Hướng dẫn sử dụng kháng sinh. Quyết định 708/QĐ-BYT ngày 02/3/2015.
3. Bộ Y tế (2018). Dược thư quốc gia Việt Nam. Nhà xuất bản Y học.
4. The Stanford guide to antimicrobial therapy 2023, D.N. Gilbert, et al., Editors.
5. Trần Thị Bảo Khánh (2023). Phân tích tình hình sử dụng kháng sinh trong điều trị viêm phổi mắc phải tại cộng đồng ở người lớn tại Bệnh viện Đa khoa tỉnh Thái Bình. Luận văn chuyên khoa I, Trường Đại học Dược Hà Nội.